Evaluation of Serum Soluble Transferrin Receptors in Detection of Iron Deficiency Anemia in Chronic Kidney Disease Patients on Hemodialysis

Document Type : Original Article

Authors

1 Department of internal medicine, faculty of medicine, Beni- Suef University

2 Department of Clinical and Chemical Pathology, faculty of medicine, Beni- Suef University

3 Department of Internal Medicine, Faculty of Medicine, Beni-Suef University

10.21608/ejmr.2024.305355.1643

Abstract

Background: A increased risk of morbidity and death is associated with anemia, which is a well-known complication of chronic kidney disease (CKD), particularly in patients with end-stage renal disease who need frequent hemodialysis. Anemia strikes between 49% and 55% of CKD patients, and it becomes more common as the illness progresses. One of the most important signs of iron deficiency in the population-based survey is anemia. Objective: In hemodialysis-dependent patients with chronic renal disease, we evaluated the accuracy of serum soluble transferrin receptors for the diagnosis of iron deficiency anemia. Subjects and methods: we recruited 90 patients of both sexes with end-stage renal disease, ranging in age from 20 to 60 years. A full blood tests, including those for iron, ferritin, total iron binding capacity, saturation with transferrin, and soluble transferrin receptor, were performed on each patient. The data was analyzed using the Pearson correlation and the independent sample t test. It was considered significant when the P value was less than 0.05. Results: The results of our research showed that mean SsTFR level was (55.14±34.2), ranged between 0.3 and 125.9,there was no statistical significant correlation with p-value >0.05 between SsTFR level and all other iron profile tests (hemoglobin, serum iron, TIBC, ferritin, and transferrin Saturation) and there was no a statistical significant higher level SsTFR with p-value 0.05 in cases on dialysis for more than 6 months, and not treated with Erythropoietin and there was  also no statistical significance difference in SsTFR level as regards level of ferritin, or T. saturation.. Conclusion: We conclude that serum soluble transferrin receptors is insignificant in detection of iron deficincy anemia in our CKD patients on hemodialysis.

Keywords

Main Subjects


  1. Portolés, J., Martín, L., Broseta, J. J et al., (2021). Anemia in chronic kidney disease: from pathophysiology and current treatments to future agents. Frontiers in Medicine, 8, 642296.
  2. Chung J, et al. (2012) Heme metabolism and erythropoiesis. Curr Opin Hematol 19(3):156-62
  3. vanrenterghem Y, Ponticelli C, Morales JM et al.,(2003) Prevalence and  management of anemiain renal transplant recipients: a  European survey. Am J Transplant. 2003; 3 (7): 835-45.
  4. Harms K, Kaiser T. Beyond soluble transferrin receptor: old challenges  and new horizons. Best Pract Res Clin Endocrinol Metab. 2015;29:799– 810.
  5. Chiang WC, Tsai TJ, Chen YM, et al .,(2002). Serum soluble  transferrin receptor reflects erythropoiesis but not iron availability  in erythropoietin-treated chronic hemodialysis patients. Clin Nephrol  2002;58:363–369.
  6. Al-Naseem, A., Sallam, A., Choudhury, S et al ., (2021). Iron deficiency without anaemia: a diagnosis that matters. Clinical Medicine, 21(2), 107.
  7. Rusch, J. A., van der Westhuizen, D. J., Gill, R. S  et al.,(2023). Diagnosing iron deficiency: Controversies and novel metrics. Best Practice & Research Clinical Anaesthesiology.
  8. El-Gendy, F. M., El-Hawy, M. A., Rizk, M. S et al ., (2018). Value of soluble transferrin receptors and sTfR/log ferritin in the diagnosis of iron deficiency accompanied by acute infection. Indian Journal of Hematology and Blood Transfusion, 34, 104–109.
  9. Gupta, D. K., Choudhary, R. K., Sharma, M., et al ., (2016). Role of soluble transferrin receptor and soluble transferrin receptor index in diagnosing iron deficiency anemia in patients with chronic kidney disease. Astrocyte, 3(3), 125.
  10. Majeed, A., Hameed, A., Aftab, I., et al., (2016). Soluble serum transferrin receptor (STFR) levels in hemodialysis patients. Annals of King Edward Medical University, 22(4).
  11. Wande, I. N., Dewi, D. A. P. R., & Sari, N. K. P. (2023). Correlation of sTfR, Hemoglobin, Serum Iron, and eGFR in Pre-dialysis CKD Patients at Sanglah Hospital. Indonesian journal of clinical pathology and medical laboratory, 29(3), 211-215.
  12. Iyawe, I. O., Adejumo, O. A., Iyawe, L. I., et al.,(2018). Assessment of iron status in predialysis chronic kidney disease patients in a Nigerian Tertiary Hospital. Saudi Journal of Kidney Diseases and Transplantation, 29(6), 1431–1440.
  13. Suega, K., Kandarini, Y., & Tubung, J. (2019). Role of soluble transferrin receptor and transferrin receptor-ferritin index to detect iron deficiency anemia in regular hemodialysis patients. Open Access Macedonian Journal of Medical Sciences, 7(1), 97.
  14. Yusra, L., Effendy, D. A., Kurniawan, L. L et al., (2022). Role of soluble transferrin receptor-An Iron marker in hemodialysis patients.
  15. Tarng DC, Huang TP(.2002 )Determinants of circulating soluble transferrin Receptor level in   chronic haemodialysis patients. Nephrol Dial Transplant.2002;17:1063–1069.
  16. Bennett J, Dolin R, Blaser M (2015). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. Elsevier/Saunders. Pp. 3196–3198. ISBN 978-0-323-40161-6.